Growth Metrics

Vertex Pharmaceuticals (VRTX) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to $1.5 billion.

  • Vertex Pharmaceuticals' Goodwill & Intangibles fell 2085.78% to $1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year decrease of 2085.78%. This contributed to the annual value of $1.5 billion for FY2025, which is 2085.78% down from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Goodwill & Intangibles stood at $1.5 billion for Q4 2025, which was down 2085.78% from $1.5 billion recorded in Q3 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Goodwill & Intangibles registered a high of $1.9 billion during Q4 2023, and its lowest value of $1.4 billion during Q2 2022.
  • Moreover, its 5-year median value for Goodwill & Intangibles was $1.6 billion (2022), whereas its average is $1.6 billion.
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Goodwill & Intangibles skyrocketed by 2176.79% in 2023, and later tumbled by 2093.14% in 2025.
  • Vertex Pharmaceuticals' Goodwill & Intangibles (Quarter) stood at $1.4 billion in 2021, then increased by 21.49% to $1.7 billion in 2022, then increased by 13.87% to $1.9 billion in 2023, then fell by 0.72% to $1.9 billion in 2024, then dropped by 20.86% to $1.5 billion in 2025.
  • Its Goodwill & Intangibles was $1.5 billion in Q4 2025, compared to $1.5 billion in Q3 2025 and $1.5 billion in Q2 2025.